Previous 10 | Next 10 |
SOUTH SAN FRANCISCO, Calif., Nov. 20, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that the company’s management will participate in the Pipe...
Weill Cornell Medicine Researchers Utilize Fluidigm Hyperion Imaging System to Identify a Phenotype of Immune Cell Activity Distinct from Other Lung Infections A Framework for Data-Driven Spatial Understanding of Lung Pathology to Inform New Treatment Approaches for COVID-19...
The FDA has issued an emergency use authorization ((EUA)) to the single-use COVID-19 diagnostic test kit from Lucira Health, a California manufacturer.The Lucira COVID-19 All-In-One at home test kit provides rapid results. To date, the Agency has authorized nearly 300 test...
SOUTH SAN FRANCISCO, Calif., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced COVID-19 Community Connect, a program to link federal, state...
SOUTH SAN FRANCISCO, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced today that the company’s management will participate in investor...
The sellers of diagnostic tests for SARS-CoV-2 and antibodies to the coronavirus are under early pressure in apparent reaction to positive interim data on Pfizer and BioNTech's COVID-19 vaccine that showed 90% efficacy. An effective vaccine, when widely deployed, will imply reduced testing de...
Fluidigm Corporation (FLDM) Q3 2020 Earnings Conference Call November 05, 2020 05:00 PM ET Company Participants Agnes Lee - Vice President, Investor Relations Chris Linthwaite - President & Chief Executive Officer Vikram Jog - Chief Financial Officer Conference Call Participants Dan Brenn...
The following slide deck was published by Fluidigm Corporation in conjunction with their 2020 Q3 earnings call. For further details see: Fluidigm Corporation 2020 Q3 - Results - Earnings Call Presentation
Fluidigm (FLDM): Q3 GAAP EPS of -$0.08 beats by $0.12.Revenue of $39.86M (+50.5% Y/Y) beats by $7.39M.Press Release For further details see: Fluidigm EPS beats by $0.12, beats on revenue
Third Q uarter T otal R evenue I n creased 50 P ercent to $ 39 .9 M illion Third Q uarter P roduct and Serv...
News, Short Squeeze, Breakout and More Instantly...
SOUTH SAN FRANCISCO, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (“Standard BioTools” or the “Company”) (Nasdaq: LAB) today announced that it will report second quarter 2024 financial results on Wednesday, July 31, 2024, after the close of the...
SOUTH SAN FRANCISCO, Calif and SALT LAKE CITY, May 28, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB) today announced that it has purchased the LSA XT system from Carterra ® , a leading provider of high-throughput large and small molecule screening and characteriza...
Ahead of plan on operating expense synergies; $50 million of $80 million target to be achieved by year-end 2024 with remaining balance in FY2025 Delivered pro forma combined revenue of $46.2 million, gross margin of 49.2%, non-GAAP gross margin of 56.3%, operating expense reduction of app...